Morgan Stanley’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.15M Sell
108,382
-16,454
-13% -$174K ﹤0.01% 5029
2025
Q1
$1.88M Sell
124,836
-64,342
-34% -$967K ﹤0.01% 4643
2024
Q4
$3.11M Sell
189,178
-263,799
-58% -$4.34M ﹤0.01% 4369
2024
Q3
$11.2M Sell
452,977
-49,011
-10% -$1.21M ﹤0.01% 3343
2024
Q2
$12.7M Sell
501,988
-199,744
-28% -$5.06M ﹤0.01% 3131
2024
Q1
$17.8M Sell
701,732
-268,454
-28% -$6.82M ﹤0.01% 2825
2023
Q4
$22M Buy
970,186
+725,384
+296% +$16.4M ﹤0.01% 3243
2023
Q3
$4.56M Sell
244,802
-37,730
-13% -$703K ﹤0.01% 3827
2023
Q2
$7.34M Buy
282,532
+22,105
+8% +$574K ﹤0.01% 3459
2023
Q1
$7.48M Buy
260,427
+68,088
+35% +$1.96M ﹤0.01% 3410
2022
Q4
$5.69M Sell
192,339
-518,349
-73% -$15.3M ﹤0.01% 3638
2022
Q3
$16.9M Buy
710,688
+40,126
+6% +$955K ﹤0.01% 2387
2022
Q2
$15M Buy
670,562
+36,317
+6% +$811K ﹤0.01% 2605
2022
Q1
$15.9M Sell
634,245
-57,414
-8% -$1.44M ﹤0.01% 2368
2021
Q4
$24.8M Buy
691,659
+125,813
+22% +$4.51M ﹤0.01% 1939
2021
Q3
$24.1M Buy
565,846
+1,634
+0.3% +$69.5K ﹤0.01% 1897
2021
Q2
$24.4M Sell
564,212
-89,421
-14% -$3.87M ﹤0.01% 1942
2021
Q1
$26.7M Buy
653,633
+556,349
+572% +$22.7M ﹤0.01% 1661
2020
Q4
$4.4M Sell
97,284
-20,392
-17% -$923K ﹤0.01% 3396
2020
Q3
$4.17M Buy
117,676
+59,349
+102% +$2.1M ﹤0.01% 2888
2020
Q2
$2.2M Buy
58,327
+1,774
+3% +$66.9K ﹤0.01% 3511
2020
Q1
$1.64M Sell
56,553
-107,807
-66% -$3.12M ﹤0.01% 3540
2019
Q4
$8.52M Sell
164,360
-572
-0.3% -$29.7K ﹤0.01% 2595
2019
Q3
$9.05M Sell
164,932
-53,481
-24% -$2.94M ﹤0.01% 2231
2019
Q2
$8.87M Buy
218,413
+71,472
+49% +$2.9M ﹤0.01% 2290
2019
Q1
$4.44M Buy
146,941
+86,804
+144% +$2.63M ﹤0.01% 2823
2018
Q4
$2.02M Sell
60,137
-24,926
-29% -$838K ﹤0.01% 3755
2018
Q3
$3.59M Sell
85,063
-417,337
-83% -$17.6M ﹤0.01% 3523
2018
Q2
$16.1M Buy
502,400
+431,738
+611% +$13.8M ﹤0.01% 1866
2018
Q1
$3.51M Sell
70,662
-2,652
-4% -$132K ﹤0.01% 3431
2017
Q4
$3.95M Buy
73,314
+4,304
+6% +$232K ﹤0.01% 3351
2017
Q3
$4M Buy
69,010
+28,800
+72% +$1.67M ﹤0.01% 3211
2017
Q2
$1.98M Sell
40,210
-49,893
-55% -$2.46M ﹤0.01% 3802
2017
Q1
$3.91M Buy
90,103
+303
+0.3% +$13.2K ﹤0.01% 3127
2016
Q4
$4.4M Buy
89,800
+4,246
+5% +$208K ﹤0.01% 3131
2016
Q3
$4.09M Sell
85,554
-2,430
-3% -$116K ﹤0.01% 2869
2016
Q2
$4.72M Sell
87,984
-47,110
-35% -$2.53M ﹤0.01% 2667
2016
Q1
$6.04M Buy
135,094
+9,621
+8% +$430K ﹤0.01% 2344
2015
Q4
$4.79M Buy
125,473
+36,006
+40% +$1.37M ﹤0.01% 2699
2015
Q3
$2.85M Sell
89,467
-2,284
-2% -$72.7K ﹤0.01% 3162
2015
Q2
$3.03M Buy
91,751
+28,783
+46% +$951K ﹤0.01% 3238
2015
Q1
$2.59M Buy
62,968
+22,465
+55% +$925K ﹤0.01% 3347
2014
Q4
$1.65M Sell
40,503
-119,254
-75% -$4.86M ﹤0.01% 3726
2014
Q3
$5.86M Buy
159,757
+49,509
+45% +$1.81M ﹤0.01% 2503
2014
Q2
$5.11M Buy
110,248
+28,754
+35% +$1.33M ﹤0.01% 2653
2014
Q1
$3.35M Sell
81,494
-24,725
-23% -$1.02M ﹤0.01% 2972
2013
Q4
$4.05M Sell
106,219
-65,492
-38% -$2.5M ﹤0.01% 2765
2013
Q3
$4.1M Buy
171,711
+129,812
+310% +$3.1M ﹤0.01% 2618
2013
Q2
$712K Buy
+41,899
New +$712K ﹤0.01% 3997